4Campbell JK,Matthews JP,Seymour JF,et al.Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma [J].Ann Oncol,2003,14(2):273-276.
5Cheson BD,Horning SJ,Coiffier B,et al.Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas.NCI Sponsored International Working Group [J].J Clin Oncol,1999,17(4):1244-1253.
6Stetler-Stevenson M,Braylan RC.Flow cytometric analysis of lymphomas and lymphoproliferative disorders [J].Semin Hematol,2001,38(2):111-123.
7Li S,Eshleman JR,Borowitz MJ.Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma [J].Am J Clin Pathol,2002,118(2):229-234.
8Hanson CA,Kurtin PJ,Katzmann JA,et al.Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma [J].Blood,1999,94(11):3889-3896.
9Naughton MJ,Hess JL,Zutter MM,et al.Bone marrow staging in patients with non-Hodgkin's lymphoma:is flow cytometry a useful test? [J].Cancer,1998,82(6):1154-1159.
10Stacchini A,Demurtas A,Godio L,et al.Flow cytometry in the bone marrow staging of mature B-cell neoplasms [J].Cytometry,2003,54B(1):10-18.
